BAM
Bellevue Asset Management’s Merck MRK Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $56.2K | Buy |
709
+34
| +5% | +$2.69K | 0.03% | 148 |
|
2025
Q1 | $60.6K | Buy |
675
+3
| +0.4% | +$270 | 0.03% | 139 |
|
2024
Q4 | $66.9K | Buy |
672
+45
| +7% | +$4.48K | 0.03% | 127 |
|
2024
Q3 | $71.3K | Buy |
627
+2
| +0.3% | +$227 | 0.04% | 127 |
|
2024
Q2 | $77.4K | Buy |
625
+1
| +0.2% | +$124 | 0.04% | 114 |
|
2024
Q1 | $82.3K | Buy |
624
+3
| +0.5% | +$396 | 0.05% | 110 |
|
2023
Q4 | $67.7K | Buy |
621
+2
| +0.3% | +$218 | 0.06% | 119 |
|
2023
Q3 | $63.7K | Buy |
619
+3
| +0.5% | +$309 | 0.04% | 114 |
|
2023
Q2 | $71.2K | Buy |
616
+2
| +0.3% | +$231 | 0.04% | 115 |
|
2023
Q1 | $65.4K | Sell |
614
-999
| -62% | -$106K | 0.04% | 120 |
|
2022
Q4 | $178K | Sell |
1,613
-189
| -10% | -$20.9K | 0.14% | 60 |
|
2022
Q3 | $156K | Buy |
1,802
+2
| +0.1% | +$173 | 0.12% | 70 |
|
2022
Q2 | $166K | Buy |
1,800
+3
| +0.2% | +$277 | 0.12% | 72 |
|
2022
Q1 | $149K | Buy |
1,797
+2
| +0.1% | +$166 | 0.09% | 87 |
|
2021
Q4 | $138K | Buy |
1,795
+3
| +0.2% | +$231 | 0.08% | 94 |
|
2021
Q3 | $136K | Buy |
1,792
+2
| +0.1% | +$152 | 0.08% | 96 |
|
2021
Q2 | $139K | Sell |
1,790
-317
| -15% | -$24.6K | 0.08% | 96 |
|
2021
Q1 | $163K | Hold |
2,107
| – | – | 0.1% | 89 |
|
2020
Q4 | $170K | Buy |
2,107
+2
| +0.1% | +$161 | 0.1% | 79 |
|
2020
Q3 | $175K | Hold |
2,105
| – | – | 0.12% | 76 |
|
2020
Q2 | $163K | Sell |
2,105
-3,375
| -62% | -$261K | 0.17% | 78 |
|
2020
Q1 | $459K | Sell |
5,480
-1,293
| -19% | -$108K | 0.48% | 42 |
|
2019
Q4 | $616K | Buy |
+6,773
| New | +$616K | 0.48% | 37 |
|